Meeting
2023 ASCO Breakthrough
A novel pathological finding, "BABA", for a prognostic factor in oral tongue carcinoma.
Authors
Daisuke Baba
National Cancer Center East, Japan, Kashiwa-Shi, Japan
Daisuke Baba , Shingo Sakashita , Masahiro Adachi , Naoya Sakamoto , Motohiro Kojima , Kazuto Matsuura , Tetsuya Nakatsura , Ryuichi Hayashi , Genichiro Ishii
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Gastrointestinal Cancer,Gynecologic Cancer,Head and Neck Cancer,Quality of Care,Genetics/Genomics/Multiomics,Healthcare Equity and Access to Care,Healthtech Innovations,Models of Care and Care Delivery,Population Health,Viral-Mediated Malignancies
Sub Track
Diagnostics
Citation
JCO Global Oncology 9, 2023 (suppl 1; abstr 92)
DOI
10.1200/GO.2023.9.Supplement_1.92
Abstract #
92
Poster Bd #
E8
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Post-treatment detection of circulating methylated BCAT1 and IKZF1 as prognostic indicators for recurrence in patients with colorectal cancer.
First Author: Graeme P. Young
Poster
2023 ASCO Genitourinary Cancers Symposium
Complimentary genomic, pathologic, and artificial intelligence analysis on low-grade noninvasive bladder cancer to predict downstream recurrence.
First Author: Kyle M. Rose
Poster
2022 ASCO Annual Meeting
Variation in recurrence rate and overall survival (OS) outcomes by disease stage and incremental impact of time to recurrence on OS in localized renal cell carcinoma (RCC).
First Author: Naomi B. Haas
Poster
2022 ASCO Annual Meeting
Liquid Biopsy for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS): A personalized cell-free tumor DNA analysis for patients with HNSCC.
First Author: Susanne Flach